Business Practice

With an approaching patent cliff in biologics, are we be about to see a rise in litigation?

PhRMA explain why the US Elections are important for the pharma industry.

It's Trump or Clinton for President. But what are the implications for pharma?

Costs of failing to communicate can cost you collaboration and investment.

Have Mylan been their own worst enemy with an imprudent pricing decision?

Emma Walmsley is chosen as GlaxoSmithKline's new CEO.

Richard Bergstrom has resigned from EFPIA - who will replace him?

Critics say a report from the UN on access to medicines ignores the real word industry

Our infographic looks at how the CPhI trade show has grown over the years.

Why is the pharma industry so despised when it has saved countless lives?